Recent advances in the treatment of colorectal cancer: a review
S Shinji, T Yamada, A Matsuda, H Sonoda… - Journal of Nippon …, 2022 - jstage.jst.go.jp
Departments of Gastrointestinal and Hepato-Biliary-Pancreatic Surgery, Nippon Medical
School, Tokyo, Japan Colorectal cancer (CRC) is the third most common cancer worldwide …
School, Tokyo, Japan Colorectal cancer (CRC) is the third most common cancer worldwide …
Epigenetic alterations in colorectal cancer: emerging biomarkers
Colorectal cancer (CRC) is a leading cause of cancer deaths worldwide. One of the
fundamental processes driving the initiation and progression of CRC is the accumulation of …
fundamental processes driving the initiation and progression of CRC is the accumulation of …
The oncosurgery approach to managing liver metastases from colorectal cancer: a multidisciplinary international consensus
R Adam, A De Gramont, J Figueras, A Guthrie… - The …, 2012 - academic.oup.com
An international panel of multidisciplinary experts convened to develop recommendations
for the management of patients with liver metastases from colorectal cancer (CRC). The aim …
for the management of patients with liver metastases from colorectal cancer (CRC). The aim …
International consensus guidelines for scoring the histopathological growth patterns of liver metastasis
PJ Van Dam, EP Van Der Stok, LA Teuwen… - British journal of …, 2017 - nature.com
Background: Liver metastases present with distinct histopathological growth patterns
(HGPs), including the desmoplastic, pushing and replacement HGPs and two rarer HGPs …
(HGPs), including the desmoplastic, pushing and replacement HGPs and two rarer HGPs …
Localization and density of immune cells in the invasive margin of human colorectal cancer liver metastases are prognostic for response to chemotherapy
Abstract Analysis of tumor-infiltrating lymphocytes (TIL) in primary human colorectal cancer
(CRC) by in situ immunohistochemical staining supports the hypothesis that the adaptive …
(CRC) by in situ immunohistochemical staining supports the hypothesis that the adaptive …
Molecular mechanisms of resistance to cetuximab and panitumumab in colorectal cancer
A Bardelli, S Siena - Journal of clinical oncology, 2010 - ascopubs.org
Personalized cancer medicine based on the genetic milieu of individual colorectal tumors
has long been postulated, but until recently this concept was not supported by clinical …
has long been postulated, but until recently this concept was not supported by clinical …
Surgical management and outcomes of colorectal cancer liver metastases
EJA Morris, D Forman, JD Thomas… - Journal of British …, 2010 - academic.oup.com
Background This population-based study investigated the frequency of hepatic resections
for colorectal cancer metastases across England and their outcome. Methods Individuals …
for colorectal cancer metastases across England and their outcome. Methods Individuals …
[HTML][HTML] Combination of surgery and chemotherapy and the role of targeted agents in the treatment of patients with colorectal liver metastases: recommendations from …
B Nordlinger, E Van Cutsem, T Gruenberger… - Annals of …, 2009 - Elsevier
The past 5 years have seen the clear recognition that the administration of chemotherapy to
patients with initially unresectable colorectal liver metastases can increase the number of …
patients with initially unresectable colorectal liver metastases can increase the number of …
Circulating DNA as a strong multimarker prognostic tool for metastatic colorectal cancer patient management care
S El Messaoudi, F Mouliere, S Du Manoir… - Clinical Cancer …, 2016 - AACR
Purpose: Circulating cell-free DNA (ccfDNA) is a valuable source of tumor material obtained
from a simple blood sampling that enables noninvasive analysis of the tumor genome. Our …
from a simple blood sampling that enables noninvasive analysis of the tumor genome. Our …
TNM staging system of colorectal carcinoma: a critical appraisal of challenging issues
G Puppa, A Sonzogni… - Archives of pathology …, 2010 - meridian.allenpress.com
Context.—Colorectal cancer is the leading cause of morbidity and death among
gastrointestinal tumors and ranks fourth after lung, breast, and ovarian cancers. Despite a …
gastrointestinal tumors and ranks fourth after lung, breast, and ovarian cancers. Despite a …